prof. MUDr. Luděk Pour, Ph.D.

2025

• Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group

  MINARIK Jiri POUR Luděk LATAL Vojtech JELINEK Tomas STRAUB Jan JUNGOVA Alexandra RADOCHA Jakub PAVLICEK Petr ŠTORK Martin PIKA Tomas KRHOVSKA Petra POPKOVA Tereza SEDLAK Frantisek SPICKA Ivan JINDRA Pavel CAPOUNOVA Vladimira MAISNAR Vladimir HAJEK Roman

  Peer-reviewed scientific article

  BMC Cancer, year: 2025, volume: 25, edition: 1, DOI

• MicroRNA Profiling of Bone Marrow Plasma Extracellular Vesicles in Multiple Myeloma, Extramedullary Disease, and Plasma Cell Leukemia

  GREGOROVÁ Jana VLACHOVÁ Monika VYCHYTILOVÁ Petra DOSTÁLOVÁ Adéla RŮŽIČKOVÁ Tereza VEČEŘA Marek RADOVÁ Lenka HLAVÁČKOVÁ POSPÍCHALOVÁ Vendula SLADEČEK Stanislava HYZDALOVA Martina KOTAŠKOVÁ Jana JAROŠOVÁ Marie MASEK Josef BENEŠOVÁ Klára JARKOVSKÝ Jiří RIHOVA Lucie BEZDEKOVA Renata ALMÁŠI Martina BOICHUK Ivanna ŠTORK Martin POUR Luděk ŠEVČÍKOVÁ Sabina

  Peer-reviewed scientific article

  Hematological Oncology, year: 2025, volume: 43, edition: 1, DOI

• Precizní medicína v hematoonkologii - léčba refrakterního mnohočetného myelomu s masivním extramedulárním postižením BRAF/MEK inhibitory

  ŠTORK Martin KOTAŠKOVÁ Jana ONDROUŠKOVÁ Eva BORSKÝ Marek MAREČKOVÁ Andrea SENDLEROVÁ Nela MAYEROVÁ Johana BRADA Michal BOICHUK Ivanna MENŠÍKOVÁ Klára ADAM Zdeněk KREJČÍ Marta SANDECKÁ Viera JELÍNKOVÁ Zuzana KRTIČKA Milan NEKUDA Vladimír BILČÍKOVÁ Michaela HRABČÁKOVÁ Viera VOJTKOVÁ Lenka JAROŠOVÁ Marie ŠLAMPA Pavel POUR Luděk

  Peer-reviewed scientific article

  Klinická onkologie, year: 2025, volume: 38, edition: 5, DOI

• Real-World Evidence on Prognostic Value of MRD in Multiple Myeloma Using Flow Cytometry

  MURONOVA Ludmila SOUCEK Ondrej ZIHALA David SEVCIKOVA Tereza POPKOVA Tereza PLONKOVA Hana VENGLAR Ondrej POUR Luděk ŠTORK Martin RIHOVA Lucie BEZDEKOVA Renata MINARIK Jiri LATAL Vojtech NOVAK Martin JUNGOVA Alexandra DEKOJOVA Tereza STRAUB Jan SPACEK Martin REZACOVA Vladimira MAISNAR Vladimir RADOCHA Jakub HAJEK Roman JELINEK Tomas

  Peer-reviewed scientific article

  European Journal of Haematology, year: 2025, volume: 114, edition: 1, DOI

2024

• An open-label, first-in-human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myeloma

  KAPOOR Prashant NATHWANI Nitya JELINEK Tomas POUR Luděk PERROT Aurore DIMOPOULOS Meletios-Athanasios HUANG Shang-Yi SPICKA Ivan CHHABRA Saurabh LICHTMAN Eben MATEOS Maria-Victoria KANAGAVEL Dheepak ZHAO Liang GUILLEMIN-PAVEAU Helene MACE Sandrine HELGI van de Velde RICHARDSON Paul G

  Peer-reviewed scientific article

  European Journal of Haematology, year: 2024, volume: 113, edition: 5, DOI

• ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study

  OCIO Enrique M EFEBERA Yvonne A HAJEK Roman STRAUB Jan MAISNAR Vladimir EVEILLARD Jean-Richard KARLIN Lionel MATEOS Maria -Victoria ORIOL Albert RIBRAG Vincent RICHARDSON Paul G NORIN Stefan OBERMUELLER Jakob BAKKER Nicolaas A POUR Luděk

  Peer-reviewed scientific article

  haematologica, year: 2024, volume: 109, edition: 3, DOI

• Circulating plasma cells in multiple myeloma

  RŮŽIČKOVÁ Tereza VLACHOVÁ Monika KOTAŠKOVÁ Jana ALMÁŠI Martina ŘÍHOVÁ Lucie ŠTORK Martin POUR Luděk ŠEVČÍKOVÁ Sabina

  Conference abstract

  Year: 2024, type: Conference abstract

• CIRCULATING TUMOR CELLS HAVE HIGH PROGNOSTIC SIGNIFICANCE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH PARASKELETAL OR EXTRAMEDULLARY PLASMACYTOMAS

  ŠTORK Martin KOTAŠKOVÁ Jana BORSKÝ Marek FIDRICHOVÁ A. ONDROUŠKOVÁ Eva MAREČKOVÁ Andrea HRABČÁKOVÁ Viera ŘÍHOVÁ L. BOICHUK Ivanna ADAM Zdeněk KREJČÍ Marta SANDECKÁ Viera JELÍNEK T. POPKOVÁ T. KNECHTOVÁ Z. RADOVÁ Lenka POLCEORVÁ L JAROŠOVÁ Marie ŠEVČÍKOVÁ Sabina HÁJEK Roman POUR Luděk

  Conference abstract

  Year: 2024, type: Conference abstract

• Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease

  ŠTORK Martin ONDROUŠKOVÁ Eva BOHÚNOVÁ Michaela BOICHUK Ivanna FRIČ Dominik ADAM Zdeněk KREJČÍ Marta SANDECKÁ Viera KNECHTOVÁ Zdeňka RADOVÁ Lenka JELÍNKOVÁ Zuzana ADLEROVÁ Taťána KRTIČKA Milan NEKUDA Vladimír BORSKÝ Marek ŠEVČÍKOVÁ Sabina JAROŠOVÁ Marie POUR Luděk

  Peer-reviewed scientific article

  Blood Cancer Journal, year: 2024, volume: 14, edition: 1, DOI

• Del(1p32) is an early and high-risk event in relapsed multiple myeloma patients with extraosseous plasmacytomas

  ONDROUŠKOVÁ Eva ŠTORK Martin BOHÚNOVÁ M. BOICHUK Ivanna FRIČ Dominik ADAM Zdeněk KREJČÍ Martin SANDECKÁ Viera KNECHTOVÁ Zdeňka RADOVÁ Lenka JELÍNKOVÁ Zuzana ADLEROVÁ Taťána KRTIČKA Milan NEKUDA Vladimír BORSKÝ Marek KOTAŠKOVÁ Jana ŠEVČÍKOVÁ Sabina JAROŠOVÁ Marie POUR Luděk

  Conference abstract

  Year: 2024, type: Conference abstract